124 related articles for article (PubMed ID: 22490152)
1. [Phenotypic differences of stroma cells in benign and malignant human prostate tissues].
Zhou H; Sun HB; Huang WB; Xu Z; Su JH; Zhu JG; Jia RP; Liu J
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):516-9. PubMed ID: 22490152
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
3. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
Ayala G; Tuxhorn JA; Wheeler TM; Frolov A; Scardino PT; Ohori M; Wheeler M; Spitler J; Rowley DR
Clin Cancer Res; 2003 Oct; 9(13):4792-801. PubMed ID: 14581350
[TBL] [Abstract][Full Text] [Related]
4. The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma.
Tomas D; Kruslin B
Prostate; 2004 Dec; 61(4):324-31. PubMed ID: 15389817
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate.
Zhang Y; Nojima S; Nakayama H; Jin Y; Enza H
Oncol Rep; 2003; 10(1):207-11. PubMed ID: 12469170
[TBL] [Abstract][Full Text] [Related]
6. Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinoma.
Tomas D; Ulamec M; Hudolin T; Bulimbasić S; Belicza M; Kruslin B
Prostate Cancer Prostatic Dis; 2006; 9(4):414-9. PubMed ID: 16652121
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
8. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
9. Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy.
Wu JP; Huang WB; Zhou H; Xu LW; Zhao JH; Zhu JG; Su JH; Sun HB
Asian J Androl; 2014; 16(5):710-4. PubMed ID: 24875819
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma.
Olapade-Olaopa EO; MacKay EH; Taub NA; Sandhu DP; Terry TR; Habib FK
Clin Cancer Res; 1999 Mar; 5(3):569-76. PubMed ID: 10100708
[TBL] [Abstract][Full Text] [Related]
11. Intensity of stromal changes predicts biochemical recurrence-free survival in prostatic carcinoma.
Tomas D; Spajić B; Milosević M; Demirović A; Marusić Z; Kruslin B
Scand J Urol Nephrol; 2010 Nov; 44(5):284-90. PubMed ID: 20459359
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
[TBL] [Abstract][Full Text] [Related]
13. Gray level entropy matrix is a superior predictor than multiplex ELISA in the detection of reactive stroma and metastatic potential of high-grade prostatic adenocarcinoma.
Jia X; Sun Y; Wang B
IUBMB Life; 2014 Dec; 66(12):847-53. PubMed ID: 25631296
[TBL] [Abstract][Full Text] [Related]
14. Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases.
Gaudin PB; Rosai J; Epstein JI
Am J Surg Pathol; 1998 Feb; 22(2):148-62. PubMed ID: 9500215
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
16. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
Wikström P; Marusic J; Stattin P; Bergh A
Prostate; 2009 Jun; 69(8):799-809. PubMed ID: 19189305
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor expression during prostate cancer progression suggests a role of this receptor in stromal cell differentiation.
Yu Y; Yang O; Fazli L; Rennie PS; Gleave ME; Dong X
Prostate; 2015 Jul; 75(10):1043-50. PubMed ID: 25833156
[TBL] [Abstract][Full Text] [Related]
18. [Characterization of stromal cell cultures from the prostatic peripheral zone of men at different ages].
Wang YC; Han BM; Wang XH; Yu SQ; Jiang Q; Zhao FJ; Hong Y; Xia SJ
Zhonghua Nan Ke Xue; 2011 Mar; 17(3):219-23. PubMed ID: 21485542
[TBL] [Abstract][Full Text] [Related]
19. c-met proto-oncogene expression in benign and malignant human prostate tissues.
Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
[TBL] [Abstract][Full Text] [Related]
20. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
